When you’re diagnosed with lung cancer, your doctor will classify it as one of two types: small cell lung cancer or non-small-cell lung cancer (NSCLC). NSCLC is far more common. About 85% of all lung ...

Jacqulyne Robichaux works for MD Anderson Cancer Center. She receives funding from the NIH, CPRIT, Takeda Pharmaceuticals and Spectrum Pharmaceuticals. She is also an inventor on patents held by MD ...

Although previously thought to be neutral, research in yeast suggests that synonymous point mutations may have strongly nonneutral effects. A group of researchers from the University of Michigan (MI, ...